A
A

Price • Acurx Pharmaceuticals

ACXP

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Historical stock price chart and annual return over the past years

-94%

4 years

% Total

ACXP
-51%

4 years

Annual Return

ACXP